SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-072061
Filing Date
2022-03-10
Accepted
2022-03-10 17:03:34
Documents
6
Effectiveness Date
2022-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 d312173ds8.htm S-8 43002
2 EX-5.1 d312173dex51.htm EX-5.1 12424
3 EX-23.2 d312173dex232.htm EX-23.2 1564
4 EX-FILING FEES d312173dexfilingfees.htm EX-FILING FEES 19307
5 GRAPHIC g312173g0309074917567.jpg GRAPHIC 2345
6 GRAPHIC g312173g0309074917801.jpg GRAPHIC 1769
  Complete submission text file 0001193125-22-072061.txt   83320
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263447 | Film No.: 22729909
SIC: 2836 Biological Products, (No Diagnostic Substances)